NM_000620.5:c.*276C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000620.5(NOS1):c.*276C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.27 in 1,182,334 control chromosomes in the GnomAD database, including 43,705 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 5037 hom., cov: 33)
Exomes 𝑓: 0.27 ( 38668 hom. )
Consequence
NOS1
NM_000620.5 3_prime_UTR
NM_000620.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.410
Publications
76 publications found
Genes affected
NOS1 (HGNC:7872): (nitric oxide synthase 1) The protein encoded by this gene belongs to the family of nitric oxide synthases, which synthesize nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biologic mediator in several processes, including neurotransmission, and antimicrobial and antitumoral activities. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter, and has been implicated in neurotoxicity associated with stroke and neurodegenerative diseases, neural regulation of smooth muscle, including peristalsis, and penile erection. This protein is ubiquitously expressed, with high level of expression in skeletal muscle. Multiple transcript variants that differ in the 5' UTR have been described for this gene but the full-length nature of these transcripts is not known. Additionally, alternatively spliced transcript variants encoding different isoforms (some testis-specific) have been found for this gene.[provided by RefSeq, Feb 2011]
NOS1 Gene-Disease associations (from GenCC):
- idiopathic achalasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NOS1 | NM_000620.5 | c.*276C>T | 3_prime_UTR_variant | Exon 29 of 29 | ENST00000317775.11 | NP_000611.1 | ||
| NOS1 | NM_001204218.2 | c.*276C>T | 3_prime_UTR_variant | Exon 30 of 30 | NP_001191147.1 | |||
| NOS1 | NM_001204213.2 | c.*276C>T | 3_prime_UTR_variant | Exon 28 of 28 | NP_001191142.1 | |||
| NOS1 | NM_001204214.2 | c.*276C>T | 3_prime_UTR_variant | Exon 28 of 28 | NP_001191143.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOS1 | ENST00000317775.11 | c.*276C>T | 3_prime_UTR_variant | Exon 29 of 29 | 1 | NM_000620.5 | ENSP00000320758.6 | |||
| NOS1 | ENST00000618760.4 | c.*276C>T | 3_prime_UTR_variant | Exon 30 of 30 | 5 | ENSP00000477999.1 | ||||
| NOS1 | ENST00000338101.8 | c.*276C>T | downstream_gene_variant | 5 | ENSP00000337459.4 |
Frequencies
GnomAD3 genomes AF: 0.253 AC: 38483AN: 152068Hom.: 5030 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
38483
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.272 AC: 280463AN: 1030148Hom.: 38668 Cov.: 34 AF XY: 0.273 AC XY: 132299AN XY: 484386 show subpopulations
GnomAD4 exome
AF:
AC:
280463
AN:
1030148
Hom.:
Cov.:
34
AF XY:
AC XY:
132299
AN XY:
484386
show subpopulations
African (AFR)
AF:
AC:
4197
AN:
21800
American (AMR)
AF:
AC:
1632
AN:
6676
Ashkenazi Jewish (ASJ)
AF:
AC:
4037
AN:
12822
East Asian (EAS)
AF:
AC:
7520
AN:
22242
South Asian (SAS)
AF:
AC:
4551
AN:
18256
European-Finnish (FIN)
AF:
AC:
5008
AN:
16590
Middle Eastern (MID)
AF:
AC:
919
AN:
2670
European-Non Finnish (NFE)
AF:
AC:
241307
AN:
888600
Other (OTH)
AF:
AC:
11292
AN:
40492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
11479
22958
34438
45917
57396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9614
19228
28842
38456
48070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.253 AC: 38511AN: 152186Hom.: 5037 Cov.: 33 AF XY: 0.256 AC XY: 19036AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
38511
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
19036
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
7869
AN:
41524
American (AMR)
AF:
AC:
3798
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1079
AN:
3472
East Asian (EAS)
AF:
AC:
1667
AN:
5172
South Asian (SAS)
AF:
AC:
1209
AN:
4812
European-Finnish (FIN)
AF:
AC:
3088
AN:
10594
Middle Eastern (MID)
AF:
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18911
AN:
68006
Other (OTH)
AF:
AC:
593
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1500
2999
4499
5998
7498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1114
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.